Atul Verma, MD, director of cardiology at McGill University Health Centre in Montreal, explained why the late-breaking PULSED-AF trial data on Medtronic’s pulsed-field ablation technology is so important for cardiologists. 

CVRx and Abbott used the second annual THT conference as an opportunity to present updated data on their signature heart failure solutions.

In comparison to a cohort of individuals who were unaffected by either condition, the differences in brain stem volume were found to be significant, according to a paper published recently in Frontiers in Neuroscience. 

A new meta-analysis suggests that when it comes to hip fractures, AI algorithms do not always live up to their hype. 

A new experimental study focused on how different sex hormones can affect the heart's ability to properly pump blood. Estradiol, the most active form of estrogen, stood out as a hormone that requires additional research.

Electromyometrial imaging creates 3D maps of contractions during labor in real-time, which can help clinicians track contraction patterns and make decisions regarding patient management.  

Steven Nissen, MD, spoke with Cardiovascular Business at ACC.23 about the late-breaking CLEAR Outcomes trial.

Researchers examined data from 34 different studies, publishing their full systematic review and meta-analysis in JAMA Pediatrics.